Using Immunoscintigraphy to Diagnose Medullary Thyroid Carcinoma
Author Information
Author(s): P Magnani, G Paganelli, C Songini, A Samuel, F Sudati, AG Siccardi, F Fazio
Primary Institution: INB-CNR, Institute H San Raffaele, University of Milan, Milan, Italy
Hypothesis
Can pretargeted immunoscintigraphy improve the diagnosis and follow-up of patients with medullary thyroid carcinoma?
Conclusion
Pretargeted immunoscintigraphy effectively localizes primary tumors and recurrences in patients with medullary thyroid carcinoma.
Supporting Evidence
- Fifty-two lesions were visualized, with all primary tumors correctly diagnosed.
- ISG detected 47 recurrences confirmed by cytology or histology.
- The smallest lesion detected was a lymph node of 4 mm in diameter.
Takeaway
Doctors used a special imaging technique to find cancer in patients' necks, and it worked really well to spot tumors that other tests missed.
Methodology
The study involved 25 patients with medullary thyroid carcinoma who underwent a three-step immunoscintigraphy procedure using biotinylated monoclonal antibodies.
Limitations
The study had a small sample size and only tested immunogenicity in 11 patients.
Participant Demographics
The participants included 10 females and 15 males, aged 18 to 68 years.
Want to read the original?
Access the complete publication on the publisher's website